4Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumors of heamatopoietic and lymphoid tissues[ M]. Lyon:IARC Press, 2008.54 - 63.
5Butterfield JH. Systemic mastocytosis : clinical manifestations and differential diagnosis [ J ]. Immuno| Allergy Clin North Am ,2006, 26(3) :487 -513.
6Soda K, Horny HP, Simonitsch I, et al. CD25 indicates the neoplastic phenotype of mast ceils : a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens [ J ]. Am J Surg Pathol, 2004,28(10) :1319 - 1325.
7Jordan JH, Walchshofer S, Jureeka W, et al. Immunohistochemical properties of bone marrow mast cells in systemic mastoeytosis: evidence for expression of CD2, CD117/Kit, and bel-xL[J]. HumPathol, 2001, 32(5) :545 -552.
8Heide R, Beishuizen A, Groot HD, et al. Mastocytosis in children : a protocol for management [ J 1. Pediatric Dermatol, 2008, 25(4) :493 -500.
9Bedeir A, Jukic DM, Wang L, et al. Systemic mastocytosis mimicking inflammatory bowel disease: a case report and discussion of gastrointestinal pathology in systemic mastocytosis [ J ]. Am J Surg Pathol, 2006,30 ( 11 ) : 1478 - 1482.
10Briley LD, Phillips CM. Cutaneous mastocytosis: a review focusing on the pediatric population[ J]. Clin Pediatr, 2008, 47 (8) :757 -761.
